IPO Detail
Sudeep Pharma Limited
MAINBOARDNot investment advice. Read RHP before applying.
Price Band
₹563 – ₹593
GMP (Indicative)
₹121
Unofficial · not guaranteed
Lot Size
25 shares
Status
Listed
Open Date
2025-11-21
Close Date
2025-11-25
Listing Date
2025-11-28
Min. Investment
₹14,825
Overview
About the Company
Sudeep Pharma Limited is a technology-driven manufacturer of excipients and specialty ingredients used in pharmaceutical, food, and nutrition industries. The company serves more than 1,100 customers across over 100 countries and operates multiple manufacturing facilities with global regulatory certifications.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Financials
Key Financial Metrics
EPS Pre IPO
—
EPS Post IPO
—
P/E Pre
53.55
P/E Post
—
ROCE
—
Debt / Equity
—
PAT Margin
—
Market Cap
6698
Financial figures sourced from official offer documents. Always verify with the RHP.
Issue
IPO Issue Details
Issue Price
₹563 – ₹593
Face Value
₹1
Issue Size
895
Fresh Issue
95
Listing At
BSE,NSE
Lead Manager
ICICI Securities Limited IIFL Capital Services Limited
Registrar
MUFG Intime India Private Limited
Lot Size
25
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation.
Investors
Anchor Investors
Various domestic and international institutional investors participated as anchor investors prior to the IPO opening.
GMP (Grey Market Premium)
GMP Overview
₹121
Updated —
+20.4% over issue price
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
GMP is unofficial and indicative. To understand interpretation logic and limitations, read our IPO Grey Market Guide or begin with what IPO GMP means.
Trend
GMP Trend
No GMP data yet. Updates will appear once available.
Investment
Market Lot Details
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 25 | 14825 |
| Retail (Max) | 13 | 325 | 192725 |
| sNII (Min) | — | — | — |
| bNII (Min) | — | — | — |
| sNII (Max) | 66 | 1650 | 978450 |
| bNII (Max) | — | — | — |
Investors can bid in multiples of the lot size. Final investment depends on the cutoff price.
Valuation
IPO Valuation Metrics
EPS Pre IPO
—
EPS Post IPO
—
P/E Pre
53.55
P/E Post
—
ROCE
—
Debt/Equity
—
RoNW
—
PAT Margin
—
Market Cap
6698
Contacts
Company & Registrar Details
Company Address: Sudeep Pharma Limited Vadodara, Gujarat India
Phone: —
Email: info@sudeeppharma.com
Website: https://www.sudeeppharma.com
Registrar: MUFG Intime India Private Limited
Registrar Phone: +91 22 4918 6270
Registrar Email: ipo.helpdesk@linkintime.co.in
Registrar Website: https://linkintime.co.in
Issue Summary
Objectives of Issue
The proceeds from the fresh issue will be primarily used for capital expenditure including purchase of machinery for production facilities and for general corporate purposes.
Ownership
Promoter Holdings
Pre Issue
89.37%
Post Issue
76.15%
Allocation
Reservation Details
QIB
50
NII
15
RII
35
Employee
—
Documents
Important Links
Performance
Listing Performance
Listing Exchange
BSE,NSE
Listing Price
₹730
Listing Gain
23.102866779089375%
Qualitative Factors
Strengths & Risks
Company Strengths
Strong global customer base across pharmaceutical and nutrition industries Wide portfolio of excipients and specialty ingredients Strong R&D capabilities and manufacturing expertise Presence in over 100 countries Established relationships with global pharmaceutical companies
Company Risks
Dependence on pharmaceutical industry demand Exposure to regulatory compliance requirements Competition from global excipient manufacturers Fluctuations in raw material prices
Schedule
Timeline
Open Date
2025-11-21
Close Date
2025-11-25
Allotment Date
2025-11-26
Refund Date
2025-11-27
Listing Date
2025-11-28
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice.
Subscription
Live Subscription Details
| Day | QIB | NII | sNII (< ₹10L) | bNII (> ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| Latest | 213.08x | 116.45x | —x | —x | 14.97x | 93.32x |
Subscription Progress
Subscription data sourced from exchange updates. Values represent times subscribed (x).
Learn how subscription categories are allocated by reading our guide on QIB, HNI and Retail IPO quota structure.
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Application
How to Apply
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Risk Disclosure
Investments in IPOs are subject to market risks. Grey Market Premium (GMP) is unofficial and indicative only — it does not guarantee listing price or returns. Read the official offer documents (DRHP / RHP) and consult a SEBI-registered financial advisor before applying. IPOCraft does not provide investment advice.
Research Before You Apply